Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...

GSK has agreed to pay $58 per RAPT share, with an upfront payment of $1.9 billion, that will give it global rights to ...

The BIM-IOL is designed to be implanted during cataract surgery, tackling IOP while restoring vision, and SpyGlass is also ...

To get full control of C-CAR031, AZ is buying out AbelZeta's 50% share of the China development and commercialisation rights ...

Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's ...

In a new pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Mohit Manrao, SVP, head of US oncology at ...

The use of AI in oncology has tremendous potential to improve many facets of cancer care, including diagnosis, drug discovery ...

The Bio-Hermes-002 study, involving 1,000 volunteers aged over 60 in the UK, US and Canada, is using finger-prick testing to ...

For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...

Sun Pharma has downplayed a rumour that it is in talks to acquire women's health specialist Organon, after a report suggested ...

Eric Bennett, CEO of Frontier Bio, and Boyang Wang, founder of Immortal Dragons, discussed 3D tissue biofabrication and ...

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...